Page 51 - IJB-3-2
P. 51

Pujiang Shi, et. al.

           types. The implantation of the cells into the subretinal   2.  Materials and Methods
           region may cause significant cell loss, and cell behavior
           after implantation may not be controllable; thus, the   2.1 Materials
           implanted retinal cells and tissue may form abnormal
           rosettes [3–5] . Cell viability and differentiation are sig-  Hematoxylin/eosin (HE), chloroform, polyethylene
           nificantly improved when the cells are transplanted with   glycol (PEG, Fluka 88276), alginate (W201502),
                  [6]
           scaffolds .                                         pluronic F-127 (P2443) and calcium chloride were
            The scaffolds can provide necessary mechanical and   purchased from Sigma-Aldrich. Polycaprolactone (PCL)
           physical supports for cell attachment, proliferation   powder was purchased from Perstorp (Mw 50000). ZO-1
           and differentiation [7,8] . However, conventional scaffold   Monoclonal Antibody, FITC (ZO1-1A12,), NucBlue®
                                                               Live ReadyProbes® reagents and ActinGreen™ 488
           fabrication methods lack precision, and are incapable
           to prepare constructs with complex designs [7,9] . Three-  ReadyProbes® reagents were purchased from Thermo
           dimensional (3D) bioprinting can precisely deliver   Fisher Scientific.
           cells and biomolecules to prepare micro-tissues, micro-  2.2 Cell culture
           organs and memetic extracellular matrix, which bring   Human retinal pigmented epithelial cell line (ARPE-19,
           researchers effective strategies for the investigation of   CRL-2302; ATCC, Rockville, MD, USA) and human
           disease progression, drug metabolism and applications   retinoblastoma cell line (Y79, HTB-18™, ATCC) were
           of tissue or organ transplantation [7,10–12] .      cultured in DMEM:F12 (ATCC) and RPMI 1640 (ATCC)
            Human retina is a highly complex vascularized tissue   media at 37 °C with 5% CO , respectively, and the media
                                                                                      2
           that contains at least 60 functionally different cell types,   was supplemented with 10% fetal bovine serum (FBS)
           including rod and cone photoreceptor cells, horizontal   and 1% antibiotics.
           cells, bipolar cells, amacrine cells, retinal ganglion cells
           as well as support cells, glial cells, etc. [1,13]  The multiple   2.3 Bioink preparation
           cells need to cooperate in concert with each other to   Alginate and pluronic were exposed and sterilized
           successfully relay visual signal to brain, and only spe-  in INTELLIRAY UV Flood 400, (λ = 320–390 nm;
           cific cells need to be replaced during certain diseases, for   density: 115 mW/cm ) for half an hour. 10% alginate
                                                                                 2
           example the retinal ganglion cells in glaucoma, or the   solution was prepared by the addition of 10 g of alginate
           photoreceptor cells in retinitis pigmentosa [1,6] . Moreover,   powder in 100 ml double-distilled water, and the
           certain areas of the retina may need replacement in some   solution was incubated in 60 °C overnight. Then, the
           conditions, for example in the treatment of age-related   10% alginate solution was mixed with pluronic to form a
           macular degeneration (AMD) that arises as the result   complex bioink consisting of 2% alginate (w/v) and 25%
           of chronic and low-grade inflammation in the central   pluronic (w/v). The bioink was stored at 4 °C for future
           outer retina, leading to the RPE and Bruch’s membrane   applications.
           degeneration [2,14] . Moreover, there are other diseases
           that will also cause macular disease [1,15] . All the diseases   2.4 ARPE-19 cell bioprinting
           lead to the malfunction of RPE and photoreceptors. In   The ARPE-19 cells upon confluence were washed with
           some extreme cases, the whole eyeball may need to   phosphate-buffered saline (PBS) three times. Then,
           be removed and replaced due to retinoblastoma; thus,   2 ml of Trypsin-EDTA (0.25%) was added onto the
           the 3D bioprinting technology is indeed necessary to   cells and incubated for 5 mins. When the cells were
           regenerate complex retina [13] . The retina models are   detached from the flask, the trypsin was neutralized by
           useful for the investigation of neurogenesis regulation   5 ml DMEM:F12 full media. The cells were counted
           and cell diversification for AMD diagnosis and early   and centrifuged, and then they were reconstituted in
           treatments. There are only few attempts and reports   cell culture media at a concentration of 1 × 10  cell/ml.
                                                                                                       6
           regarding retinal regeneration and in vitro retina models.   The cell solution was transferred into a cartridge for
           In this paper, the 3D bioprinting technology for creation   microvalve-based bioprinting. The bioprinting procedure
           of RPE (ARPE-19) and photoreceptors (Y79) retina    was based on the drop-by-drop pattern to achieve a final
           equivalent is reported, and the printed construct may   seeding density of 2,786 ± 492 cells/cm  on an ultrathin
                                                                                                 2
           serve as a meaningful retina model for the investigation   membrane. The ultrathin membrane was fabricated
           of RPE and Y79 interactions, and retina-related disease   according to our published protocol [16] . Then, the cells
           mechanism, treatment options and tissue regenerative   on the ultrathin membrane were further cultured for two
           strategies.                                         weeks.

                                       International Journal of Bioprinting (2017)–Volume 3, Issue 2       139
   46   47   48   49   50   51   52   53   54   55   56